Top-News
Dienstag,
07.05.2013 17:15
von
PR Newswire
| Aufrufe: 165
International Drug & Explosives Detection Company IDenta Corp is bidding on a second important French tender.
Ein Mann liest Wirtschaftsnachrichten (Symbolbild).
pixabay.com
PR Newswire
JERUSALEM, May 7, 2013
JERUSALEM, May 7, 2013 /PRNewswire/ -- IDenta Corp. (OTC: IDTA) CEO Yaacov Shoham today made the following announcement.
Mr Shoham stated, "In the last weeks IDenta Corp has submitted through our representative in France - ISIS ANALYTICS- www.isisanalytics.com, the official papers and the prices to an additional large tender in France:
The new tender is for the French custom, a very large tender estimated to 4 million Euro.
The tender is for a 4 years period (2013-2017) and is to supply drug detectors, for all the French custom stations.
The new tender is additional to the tender won already by IDenta Corp - the tender for the National Police and for the different French prisons, released last Friday, May 3, 2013.
Many of the different French law enforcement agencies (including the French customs) are already using IDenta's different products (drug detectors, explosive identifiers, precursors, BTK). We at IDenta Corp are confident that in a reasonable time all the different detectors used by French authorities will be exclusively IDenta's detectors.
Isis Analytics - the French representative is making also significant progresses in the French retail market.
In 2013 - we have a good chance to penetrate the French retail market also."
IDenta's entire product line may be found at www.Identa-corp.com, www.drugsdetector.com and www.touchandknowusa.com
ABOUT IDENTA
Since 2003, IDenta Corporation has been recognized as a worldwide leader in the development of proprietary on-site drug, drug precursor and explosive detection kits. IDenta develops, manufactures and distributes products for both the professional and civil markets which consistently pass the highest qualifications and testing procedures of law enforcement and security agencies around the world.
DISCLAIMER
Certain of the statements contained herein may be, within the meaning of the federal securities laws, "forward-looking statements" that are subject to risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. These forward-looking statements are based on management's expectations as of the date hereof, and the company does not undertake any responsibility to update any of these statements in the future.
For Investor Relations, lobbying interests or information concerning IDenta's products internationally or the development of new chemical detectors, contact: Yaacov Shoham, IDenta Corp., CEO, Tel: +972-52-6554487, fpi@drugsdetector.com, www.drugsdetector.com www.identa-corp.com www.touchandknowusa.com
Contact:
Contact:
Yaacov Shoham
IDenta Corp.
CEO
Tel: +972-52-6554487
fpi@drugsdetector.com
http://www.identa.biz
CONTACT: mailto:fpi@drugsdetector.com
SOURCE IDenta Corp.
Werbung
Mehr Nachrichten zur Identa Aktie kostenlos abonnieren
E-Mail-Adresse
Bitte überprüfe deine die E-Mail-Adresse.
Benachrichtigungen von ARIVA.DE
(Mit der Bestellung akzeptierst du die Datenschutzhinweise)
(Mit der Bestellung akzeptierst du die Datenschutzhinweise)
-1
Vielen Dank, dass du dich für unseren Newsletter angemeldet hast. Du erhältst in Kürze eine E-Mail mit einem Aktivierungslink.
Hinweis: ARIVA.DE veröffentlicht in dieser Rubrik Analysen, Kolumnen und Nachrichten aus verschiedenen Quellen. Die ARIVA.DE AG ist nicht verantwortlich für Inhalte, die erkennbar von Dritten in den „News“-Bereich dieser Webseite eingestellt worden sind, und macht sich diese nicht zu Eigen. Diese Inhalte sind insbesondere durch eine entsprechende „von“-Kennzeichnung unterhalb der Artikelüberschrift und/oder durch den Link „Um den vollständigen Artikel zu lesen, klicken Sie bitte hier.“ erkennbar; verantwortlich für diese Inhalte ist allein der genannte Dritte.
